Croda

Photo
24.05.2023 • News

Croda Partners on Vaccine Adjuvants

UK specialty chemicals company Croda has signed partnership agreements with US companies Amyris and Botanical Solutions Inc (BSI) to source sustainable vaccine adjuvants.

Photo
08.02.2023 • News

Croda Acquires South Korean Biotech Firm

UK specialty chemicals company Croda International has agreed to buy Solus Biotech, a South Korean company specializing in ceramide and phospholipid technologies and with emerging capabilities in natural retinol. The purchase price is about £232 million on a debt-free, cash-free basis.

Photo
01.07.2022 • News

Croda Wins US Backing for Lipid Systems Expansion

UK specialty chemical company Croda International will receive up to $75 million from the US government to expand its US capacity to produce ingredients for lipid systems used in novel therapeutic drugs, such as mRNA vaccines.

Photo
04.01.2022 • News

Cargill Takes Croda’s PTIC Business

US food giant Cargill has agreed to buy most of Croda’s Performance Technologies and Industrial Chemicals (PTIC) business for €915 million on a cash-free, debt-free basis. The acquisition of the UK group will boost Cargill’s bio-industrial footprint, better serving manufacturers seeking greener ingredients.

Photo
11.05.2021 • News

Croda Reviews PTIC businesses

Croda International has announced it is undertaking a strategic review of its Performance Technologies and Industrial Chemicals (PTIC) businesses. The primary aim, said the UK specialty chemicals company, will be to establish what type of ownership structure best serves the businesses going forward and create a stronger platform for its future growth.

Photo
20.11.2020 • News

Croda to Take Iberchem for €820 Million

UK specialty chemical company Croda has agreed to buy Spain’s Iberchem, marking its entry into the flavors and fragrances market. Croda will pay owner French investment group Eurazeo €820 million on a debt-free, cash-free basis.

Photo
18.11.2020 • News

Croda Supplies Excipients for Pfizer’s Covid-19 Vaccine

UK specialty chemical company Croda International has agreed to supply Pfizer with novel excipients used to make the drugmaker’s Covid-19 vaccine candidate. The contract, which is for a term of five years, enables Croda to initially supply four component excipients for the first three years of the agreement.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.